Schizophreniform Disorders
Information
- Disease name
- Schizophreniform Disorders
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05658510 | Active, not recruiting | Phase 3 | Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) | November 21, 2022 | March 30, 2025 |
| NCT00419146 | Completed | Phase 2/Phase 3 | Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants | September 2001 | April 2004 |
| NCT04673851 | Completed | N/A | Horyzons: Implementation in Clinical Practice | January 19, 2021 | August 31, 2023 |
| NCT00407277 | Completed | N/A | Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia | February 2007 | |
| NCT00222495 | Completed | N/A | A Comparative Study of New Medications for Psychosis in Adolescents | August 2002 | August 2006 |
| NCT04173572 | Completed | N/A | Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial | December 20, 2019 | March 23, 2022 |
| NCT04268303 | Completed | Phase 3 | Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia | January 24, 2020 | May 6, 2020 |
| NCT04418011 | Completed | N/A | Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders | November 30, 2020 | February 2, 2023 |
| NCT00595504 | Completed | Phase 4 | Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia | January 2008 | March 2010 |
| NCT00796081 | Completed | Phase 1 | A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder | January 2006 | August 2006 |
| NCT01082588 | Completed | Phase 4 | Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia | June 2010 | September 2012 |
| NCT03067311 | Completed | N/A | Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy | October 3, 2016 | March 30, 2020 |
| NCT03079024 | Completed | N/A | Minnesota Community-Based Cognitive Training in Early Psychosis | May 19, 2017 | March 26, 2022 |
| NCT03187769 | Completed | Phase 3 | Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder | June 8, 2017 | January 3, 2022 |
| NCT03510741 | Completed | Phase 2 | Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder. | January 1, 2019 | March 30, 2021 |
| NCT03559426 | Completed | Phase 4 | Research Into Antipsychotic Discontinuation and Reduction Trial | March 24, 2016 | March 10, 2022 |
| NCT06041646 | Completed | Phase 4 | Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder | October 12, 2023 | April 29, 2024 |
| NCT03848234 | Completed | Phase 3 | Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder | December 4, 2015 | July 29, 2016 |
| NCT00161057 | Completed | Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment | December 2001 | September 2008 | |
| NCT05784948 | Completed | N/A | Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis | April 8, 2020 | June 9, 2021 |
| NCT05416658 | Not yet recruiting | N/A | Shared Decision Making for Antipsychotic Medications | January 1, 2025 | June 30, 2025 |
| NCT05974527 | Not yet recruiting | Phase 4 | Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department | September 1, 2023 | June 30, 2026 |
| NCT06278246 | Not yet recruiting | Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography | February 2024 | February 2029 | |
| NCT03974620 | Not yet recruiting | N/A | Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia | December 1, 2024 | December 30, 2024 |
| NCT06423651 | Recruiting | N/A | Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders | September 1, 2022 | December 31, 2025 |
| NCT04004416 | Recruiting | Phase 4 | Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis | January 16, 2020 | February 28, 2025 |
| NCT04113993 | Recruiting | Phase 4 | Bazedoxifene -Treatment for Women With Schizophrenia | October 7, 2019 | December 31, 2025 |
| NCT04298450 | Recruiting | N/A | ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention | September 21, 2020 | December 2025 |
| NCT04497857 | Recruiting | N/A | Academic-Community EPINET (AC-EPINET) | March 16, 2022 | August 31, 2024 |
| NCT05109065 | Recruiting | Peripheral Immune System in Individuals With Schizophrenia | March 1, 2021 | June 1, 2025 | |
| NCT05538832 | Recruiting | Early Phase 1 | Remote State Representation in Early Psychosis | July 27, 2022 | March 31, 2025 |
| NCT05756855 | Recruiting | N/A | Young Adults With Violent Behavior During Early Psychosis | March 19, 2024 | August 2027 |
| NCT05877716 | Recruiting | N/A | EPI-MINN: Targeting Cognition and Motivation - National | May 30, 2023 | July 2025 |
| NCT06002958 | Recruiting | N/A | Horyzons: Implementation and Integration in Clinical Practice | January 8, 2024 | October 31, 2024 |
| NCT06118268 | Recruiting | N/A | iTBS to Enhance Social Cognition in People With Psychosis | April 18, 2023 | April 2027 |
| NCT00515489 | Terminated | Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients | November 2001 | August 2002 | |
| NCT03632278 | Unknown status | N/A | Mindfulness Psychoeducation Program for Schizophrenia | June 3, 2018 | December 31, 2019 |
| NCT04093518 | Unknown status | Phase 3 | Estradiol as add-on to Antipsychotics | December 2, 2019 | November 1, 2020 |
| NCT00157313 | Unknown status | N/A | Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode Psychosis | January 1998 | December 2022 |
| NCT03919760 | Unknown status | Early Psychosis Intervention - Spreading Evidence-based Treatment | January 3, 2020 | May 31, 2024 |